Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
9.57
-0.48 (-4.78%)
At close: Jun 27, 2025, 4:00 PM
9.55
-0.02 (-0.21%)
After-hours: Jun 27, 2025, 7:11 PM EDT
Dyne Therapeutics Stock Forecast
Stock Price Forecast
The 15 analysts that cover Dyne Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $43.6, which forecasts a 355.59% increase in the stock price over the next year. The lowest target is $17 and the highest is $66.
Price Target: $43.6 (+355.59%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Dyne Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 5 | 5 | 7 | 7 | 7 | 9 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 12 | 12 | 12 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +213.48% | Jun 26, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +422.47% | Jun 18, 2025 |
| Baird | Baird | Buy Maintains $46 → $32 | Buy | Maintains | $46 → $32 | +234.38% | Jun 18, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $50 | Strong Buy | Maintains | $50 | +422.47% | Jun 17, 2025 |
| Raymond James | Raymond James | Buy Initiates $37 | Buy | Initiates | $37 | +286.62% | Jun 11, 2025 |
Financial Forecast
Revenue This Year
n/a
from 716.08M
Revenue Next Year
n/a
EPS This Year
-4.08
from -3.37
EPS Next Year
-3.91
from -4.08
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 9.6M | 208.7M | ||
| Avg | n/a | 1.0M | 120.9M | ||
| Low | n/a | n/a | 24.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 20,245.0% | ||
| Avg | - | - | 11,687.5% | ||
| Low | - | - | 2,287.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.53 | -3.21 | -2.27 | ||
| Avg | -4.08 | -3.91 | -3.20 | ||
| Low | -4.43 | -4.71 | -4.67 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.